Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Ovarian cancer: recognition and initial management

Clinical guideline
Reference number: CG122
Published: 27 April 2011
Last updated: 02 October 2023

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 431 KB)

Published:

01 December 2015
Comments form (MSWord 18 KB)

Published:

01 December 2015

Stakeholder list updated

Stakeholder list (PDF 45 KB)

Published:

27 November 2015

Other information

Evidence update (PDF 406 KB)

Published:

01 January 2013

Background information

Press release information
2011/071 Improved testing for ovarian cancer could save lives (PDF 89 KB)

Published:

06 December 2013
Table of stakeholder comments on the guidance consultation and developer responses (PDF 1.41 MB)

Published:

08 February 2011

Remit

Remit (PDF 14 KB)

Published:

01 November 2007

Guideline development and consultation

Guideline development and consultation
Equalities Impact Assessment Form (PDF 46 KB)

Published:

06 May 2011
Guideline consultation information
Full guideline for consultation information
Full guideline for consultation (PDF 1.73 MB)

Published:

21 October 2010
NICE guideline for consultation (PDF 211 KB)

Published:

24 September 2010
Evidence review (PDF 2.93 MB)

Published:

24 September 2010
Comments proforma (MSWord 47 KB)

Published:

24 September 2010
Confidentiality agreement (MSWord 51 KB)

Published:

24 September 2010
Guideline consultation - press release information
Ovarian Cancer draft consultation press release (PDF 73 KB)

Published:

06 December 2013
List of registered stakeholders (PDF 131 KB)

Published:

12 January 2011
GDG membership list (PDF 14 KB)

Published:

16 April 2009
Minutes for GDG meetings
GDG 10 minutes: 17 - 18 June 2010 (PDF 11 KB)

Published:

13 August 2010
GDG 9 minutes: 27 April 2010 (PDF 19 KB)

Published:

14 July 2010
GDG 8 minutes: 10 December 2009 (PDF 9.8 KB)

Published:

21 May 2010
GDG 7 minutes: 25 January 2010 (PDF 10 KB)

Published:

18 May 2010
GDG 6 minutes: 10 December 2009 (PDF 10 KB)

Published:

18 May 2010
GDG 5 minutes: 26 October 2009 (PDF 18 KB)

Published:

21 January 2010
GDG 3 minutes: 13 July 2009 (PDF 8.4 KB)

Published:

18 May 2010
GDG 2 minutes: 9 June 09 (PDF 16 KB)

Published:

17 July 2009
GDG 1 minutes: 27 - 28 April 09 (PDF 24 KB)

Published:

19 June 2009

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Draft scope consultation information
Draft scope (PDF 35 KB)

Published:

18 February 2009
Comments proforma (MSWord 43 KB)

Published:

18 February 2009
Final scope (PDF 32 KB)

Published:

19 June 2009
Scoping workshop notes (PDF 51 KB)

Published:

25 March 2009

Pre-publication check

Pre-publication check information
Full guideline for pre-publication check (PDF 1.44 MB)

Published:

03 February 2011
Table of stakeholder comments on the guidance consultation and developer responses (PDF 1.41 MB)

Published:

08 February 2011
Pre-publication check reporting form (MSWord 48 KB)

Published:

03 February 2011